Progress with interferon in CML--results of the MRC UK CML III study.
527 patients with CML were entered into the multicentre randomised MRC CML III study comparing IFN-alpha n1 to standard chemotherapy, either busulphan or hydroxyurea. Haematologic response to IFN as assessed by the level of control of the WCC predicted cytogenetic response to IFN. Cytogenetic respon...
| Main Authors: | , , |
|---|---|
| Format: | Conference item |
| Published: |
1996
|